Antidiabetic Potential of Phytochemicals Found in Vernonia amygdalina
Open Access
- 26 March 2024
- journal article
- review article
- Published by Wiley in Journal of Chemistry
- Vol. 2024, 1-12
Abstract
Type 2 diabetes mellitus (T2DM), or insulin-independent diabetes mellitus, is a worldwide health concern. Diabetes affects roughly 415 million individuals worldwide, with 193 million undiagnosed cases. The number of people afflicted in the following decades is predicted to double. Although various synthetic medications are currently available to treat/manage T2DM, their side effects compel researchers to seek novel treatment options. Because of their affinity for biological receptors and broad bioactivity, nature has long been a source of innovative medication. V. amygdalina is one of the numerous natural productswith antidiabetic properties. Several studies have shown that the extracts have antidiabetic effects in vitro and in vivo. This review examined the antidiabetic and pharmacokinetic characteristics of phytoconstituents found in V. amygdalina.Keywords
Funding Information
- King Khalid University (RCAMS/KKU/0018-22)
This publication has 98 references indexed in Scilit:
- Effects of vernonia amygdalina fractionate on glutathione reductase and glutathione-S-transferase on alloxan induced diabetes wistar ratBiocatalysis and Agricultural Biotechnology, 2021
- In vitro and in silico inhibition of α-amylase, α-glucosidase, and aldose reductase by the leaf and callus extracts of Vernonia anthelmintica (L.) Willd.Advances in Traditional Medicine, 2021
- A Review of African Medicinal and Aromatic Plants2017
- Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activationBiochemical Pharmacology, 2013
- Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test: effects on hepatic glucose release and glycaemiaCell Biochemistry and Function, 2007
- Investigation on the absorption kinetics of chlorogenic acid in rats by HPLCArchives of Pharmacal Research, 2007
- MAFA controls genes implicated in insulin biosynthesis and secretionDiabetologia, 2006
- Investigating the safety of plants used in South African traditional medicine: Testing for genotoxicity in the micronucleus and alkaline comet assaysEnvironmental and Molecular Mutagenesis, 2003
- Steroid glucosides from vernonia amygdalina, a possible chimpanzee medicinal plantPhytochemistry, 1993
- Blood sugar lowering effect of Vernonia amygdalina Del, in an experimental rabbit modelPhytotherapy Research, 1992